Welcome to Advanced Search

Slco1a5/Slco1b2-KO(SD)

Strain Name：SD-Slco1a5^em1Slco1b2^em1Smoc Strain State：Developing | Cat. NO.：NR-KO-205073

Exon 1-16 of Slco1a5 and exon1-15 of Slco1b2 gene was deleted to generate Slco1a5/Slco1b2 knockout rats.

Alb-ALB*K573P-ALB*K573P/hALB(SD)

Strain Name：SD-Alb^{em1(pALB-ALB*K573P-pA-pALB-ALB*K573P-pA)}Alb^{em3(hALB)Smoc} Strain State：Developing | Cat. NO.：NR-KI-250101

The pALB-ALB*K573P-pA-pALB-ALB*K573P-pA expression cassette was knocked into the Alb gene of NR-HU-200001 rats.

A7r5

Strain Name：A7r5
Strain State ： Validation of tumorigenic capacity |  Cat. NO.：NM-S21A

rat thoracic aorta smooth muscle cell line

INS-1

Strain Name：INS-1
Strain State ： Validation of tumorigenic capacity |  Cat. NO.：NM-S10

Rat islet cell line

Decreased c-rel activation contributes to aberrant interleukin-2 expression in CD4(+)T cells of aged rats

Model Organisms：大鼠 Product & Service：N/A Research field：N/A

Rat

Positive selection rather than relaxation of functional constraint drives the evolution of vision during chicken...

Model Organisms：斑马鱼 Product & Service：VIT Research field：Visual development

vit基因 鸡 光感受器

The Abundant Distribution and Duplication of SARS-CoV-2 in the Cerebrum and Lungs Promote a High Mortality Rate in...

Model Organisms：小鼠 Product & Service：hACE2 Research field：SARS-CoV-2

Shanghai Model Organisms Jinshan R&D Base officially put into operation

Shanghai Model Organisms

After the base is put into operation, SMOC’s capability to provide genetically modified rat/mouse models and technical services including gene function research and drug development will be greatly enhanced.

Join Our Webinar: Applications of Humanized Mouse Models in Preclinical Research

Humanized mouse models preclinical research targeted therapies webinar oncology drug development preclinical therapeutic advancements immune system models animal modeling services

Join GenoBioTX's webinar on July 25th to explore the latest advancements in humanized mouse models for preclinical research. Learn how these models are transforming targeted therapy development across various diseases. Featuring expert insights from Dr. Derek Reznik, discover the generation and application of humanized immune system models in oncology drug development. Don't miss this opportunity to enhance your knowledge in cutting-edge preclinical therapeutic advancements. Register now!

Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.